Amicus Therapeutics to Announce Third Quarter 2020 Financial Results on November 5, 2020
October 22 2020 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company
will host a conference call and live audio webcast on Thursday,
November 5, 2020 at 8:30 a.m. ET to discuss financial results for
the third quarter ended September 30, 2020.
Interested participants and investors may access
the conference call by dialing 877-303-5859 (U.S./Canada) or
678-224-7784 (international), conference ID: 7788189. A live audio
webcast and related presentation materials can also be accessed via
the Investors section of the Amicus Therapeutics corporate website
at ir.amicusrx.com. Web participants are encouraged to register on
the website 15 minutes prior to the start of the call.
A replay of the call will be available for seven
days beginning at 11:30 a.m. ET. Access numbers for this replay are
855-859-2056 (U.S./Canada) and 404-537-3406 (international);
conference ID: 7788189.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow on Twitter and
LinkedIn.
CONTACT:
Investors:Amicus
TherapeuticsAndrew FaughnanDirector, Investor
Relationsafaughnan@amicusrx.com (609) 662-3809
Media:Amicus TherapeuticsDiana
MooreHead of Global Corporate
Communicationsdmoore@amicusrx.com(609) 662-5079
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Sep 2023 to Sep 2024